JP2014520149A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014520149A5 JP2014520149A5 JP2014517100A JP2014517100A JP2014520149A5 JP 2014520149 A5 JP2014520149 A5 JP 2014520149A5 JP 2014517100 A JP2014517100 A JP 2014517100A JP 2014517100 A JP2014517100 A JP 2014517100A JP 2014520149 A5 JP2014520149 A5 JP 2014520149A5
- Authority
- JP
- Japan
- Prior art keywords
- protein
- composition
- luke
- lukd
- isolated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161498596P | 2011-06-19 | 2011-06-19 | |
| US61/498,596 | 2011-06-19 | ||
| PCT/US2012/043179 WO2012177658A2 (en) | 2011-06-19 | 2012-06-19 | Methods of treating and preventing staphylococcus aureus infections and associated conditions |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017130030A Division JP6452765B2 (ja) | 2011-06-19 | 2017-07-03 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014520149A JP2014520149A (ja) | 2014-08-21 |
| JP2014520149A5 true JP2014520149A5 (https=) | 2015-07-23 |
| JP6170913B2 JP6170913B2 (ja) | 2017-07-26 |
Family
ID=47423177
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014517100A Active JP6170913B2 (ja) | 2011-06-19 | 2012-06-19 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
| JP2017130030A Active JP6452765B2 (ja) | 2011-06-19 | 2017-07-03 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
| JP2018231287A Active JP6758363B2 (ja) | 2011-06-19 | 2018-12-11 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
| JP2020146494A Active JP7129451B2 (ja) | 2011-06-19 | 2020-09-01 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017130030A Active JP6452765B2 (ja) | 2011-06-19 | 2017-07-03 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
| JP2018231287A Active JP6758363B2 (ja) | 2011-06-19 | 2018-12-11 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
| JP2020146494A Active JP7129451B2 (ja) | 2011-06-19 | 2020-09-01 | 黄色ブドウ球菌感染および関連状態を治療および予防する方法 |
Country Status (20)
| Country | Link |
|---|---|
| US (7) | US9091689B2 (https=) |
| EP (3) | EP3777885A1 (https=) |
| JP (4) | JP6170913B2 (https=) |
| KR (1) | KR102050267B1 (https=) |
| CN (3) | CN109893644A (https=) |
| AU (1) | AU2012273123C1 (https=) |
| BR (2) | BR112013032774B1 (https=) |
| CA (1) | CA2839554C (https=) |
| CL (2) | CL2013003650A1 (https=) |
| DK (1) | DK3403669T3 (https=) |
| ES (2) | ES2684088T3 (https=) |
| HR (1) | HRP20201265T1 (https=) |
| HU (1) | HUE051832T2 (https=) |
| IL (2) | IL229922B (https=) |
| LT (1) | LT3403669T (https=) |
| MX (2) | MX340446B (https=) |
| NZ (1) | NZ764564A (https=) |
| RU (1) | RU2635462C2 (https=) |
| SI (1) | SI3403669T1 (https=) |
| WO (1) | WO2012177658A2 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ764564A (en) | 2011-06-19 | 2022-10-28 | Univ New York | Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| US9657103B2 (en) | 2012-05-02 | 2017-05-23 | New York University | Methods of treating and preventing Staphylococcus aureus infections and associated conditions |
| CN110420316A (zh) | 2013-06-18 | 2019-11-08 | 纽约大学 | 参与金黄色葡萄球菌杀白细胞素的细胞毒性的细胞因素：新型治疗靶点 |
| RU2016119052A3 (en) * | 2013-10-17 | 2018-09-10 | Arsanis Biosciences Gmbh | Cross-reactive Staphylococcus aureus antibody sequences |
| CA2932819A1 (en) * | 2013-12-09 | 2015-06-18 | New York University | Compositions and methods for phagocyte delivery of anti-staphylococcal agents |
| BE1022875B1 (fr) * | 2014-03-26 | 2016-09-30 | Glaxosmithkline Biologicals S.A. | Compositions pour une immunisation contre staphylococcus aureus |
| US20180017559A1 (en) * | 2014-08-12 | 2018-01-18 | Arsanis Biosciences Gmbh | Predicting s. aureus disease |
| CN107873034A (zh) * | 2015-04-17 | 2018-04-03 | 阿尔萨尼斯生物科学有限责任公司 | 抗金黄色葡萄球菌抗体组合制剂 |
| JP2018517708A (ja) * | 2015-06-05 | 2018-07-05 | ニューヨーク・ユニバーシティ | 抗ブドウ球菌生物学的薬剤のための組成物及び方法 |
| CN105641689B (zh) * | 2016-01-21 | 2024-09-10 | 浙江海隆生物科技股份有限公司 | 一种奶牛金黄色葡萄球菌β-溶血素亚单位疫苗的制备方法及应用 |
| EP3464349A4 (en) * | 2016-05-23 | 2020-08-26 | New York University | COMPOSITIONS AND METHODS ASSOCIATED WITH ANTIBODIES TARGETING STAPHYLOCCAL LEUCOTOXINS |
| CR20190249A (es) | 2016-10-21 | 2019-10-16 | Socpra Sciences Et Genie Sec | Constructos de vacuna y sus usos contrainfecciones causadas por staphylococcus |
| US20200057075A1 (en) * | 2017-02-20 | 2020-02-20 | The Regents Of The University Of California | Serologic assay for silent brain ischemia |
| CN107224575B (zh) * | 2017-03-06 | 2018-11-09 | 浙江海隆生物科技有限公司 | 奶牛金黄色葡萄球菌乳房炎亚单位疫苗的组合物及其制备方法和应用 |
| CN106749652A (zh) * | 2017-03-14 | 2017-05-31 | 天津喜诺生物医药有限公司 | 一种金黄色葡萄球菌肽聚糖的多克隆抗体 |
| AU2018379996A1 (en) | 2017-12-05 | 2020-06-25 | BioPlx, Inc. | Methods and compositions to prevent microbial infection |
| JP7525471B2 (ja) | 2018-07-24 | 2024-07-30 | メディミューン，エルエルシー | Ｓ．アウレウス（Ｓ．ａｕｒｅｕｓ）クランピング因子Ａ（ＣｌｆＡ）に対する抗体 |
| JP7219512B2 (ja) * | 2019-02-28 | 2023-02-08 | エイチエルビー サイエンス インコーポレイテッド | 抗菌活性を有するポリペプチド、これを含む敗血症の予防または治療用組成物、および抗菌用組成物 |
| CN111423516B (zh) * | 2020-04-01 | 2022-02-11 | 广州佰斯伦医疗器械有限公司 | 一种蛋白及其在创口修复及抑菌中的应用 |
| CN111398194B (zh) * | 2020-04-10 | 2020-11-03 | 上海华茂药业有限公司 | 一种用于测定艾考糊精中肽聚糖的方法 |
| CN112851770B (zh) * | 2021-02-05 | 2022-10-04 | 中国人民解放军陆军军医大学 | 一种用于诊断或防治金黄色葡萄球菌感染的α溶血素抗原表位肽及其应用 |
| CN114317787A (zh) * | 2021-12-29 | 2022-04-12 | 成都大学 | 吸附磁珠及其试剂盒和用途以及检测金黄色葡萄球菌的方法 |
| CN115991766B (zh) * | 2023-03-13 | 2025-01-14 | 广州庆毅生物医药科技有限公司 | 一种细菌抗原检测试剂盒及其应用 |
| CN119431528B (zh) * | 2024-10-28 | 2025-10-14 | 中国人民解放军陆军军医大学 | 一种金黄色葡萄球菌毒素LukG抗原表位肽及其应用 |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2321892T3 (es) | 1998-09-14 | 2009-06-12 | Nabi Biopharmaceuticals | Composiciones de beta-glucanos e inmunoglobulinas especificas. |
| AT410798B (de) * | 2001-01-26 | 2003-07-25 | Cistem Biotechnologies Gmbh | Verfahren zur identifizierung, isolierung und herstellung von antigenen gegen ein spezifisches pathogen |
| AU2002306849A1 (en) | 2001-03-21 | 2002-10-08 | Elitra Pharmaceuticals, Inc. | Identification of essential genes in microorganisms |
| GB0107661D0 (en) * | 2001-03-27 | 2001-05-16 | Chiron Spa | Staphylococcus aureus |
| US20030171563A1 (en) | 2001-05-18 | 2003-09-11 | Mcnamara Peter J. | Regulators of bacterial virulence factor expression |
| US7288654B2 (en) | 2003-02-07 | 2007-10-30 | Takeda Pharmaceutical Company Ltd | Fused-ring pyridine derivative, process for producing the same, and use |
| IL157398A0 (en) | 2003-08-14 | 2004-02-19 | Hadasit Med Res Service | Pharmaceutical compositions comprising ccr5 antagonists |
| US7622125B2 (en) | 2004-05-05 | 2009-11-24 | Novartis Vaccines And Diagnostics, Inc. | Polycistronic HIV vector constructs |
| NZ553776A (en) * | 2004-09-22 | 2010-05-28 | Glaxosmithkline Biolog Sa | Immunogenic composition comprising staphylococcal PNAG and Type 5 and/or 8 Capsular polysaccharide or oligosaccharide. |
| WO2007062150A2 (en) | 2005-11-25 | 2007-05-31 | University Of Medicine And Dentistry Of New Jersey | Leukotoxin compositions and therapeutic methods |
| US20110143992A1 (en) | 2006-02-13 | 2011-06-16 | Dennis Taub | Methods and Compositions Related to GHS-R Antagonists |
| MX2008014296A (es) | 2006-06-12 | 2009-03-06 | Pfizer Prod Inc | Antagonista de ccr5 para mejorar la restitucion inmunitaria y tratar la infeccion oportunista en pacientes con vih. |
| US20080131457A1 (en) | 2006-06-12 | 2008-06-05 | Nabi Biopharmaceuticals | Use of alpha-toxin for treating and preventing staphylococcus infections |
| JP2008013447A (ja) * | 2006-07-03 | 2008-01-24 | Juntendo | 毒素検出方法 |
| JP2010519216A (ja) | 2007-02-15 | 2010-06-03 | ファイザー・リミテッド | Ｃｃｒ５拮抗薬のための医薬組成物および方法 |
| WO2010111617A2 (en) | 2009-03-27 | 2010-09-30 | Van Andel Research Institute | Parathyroid hormone peptides and parathyroid hormone-related protein peptides and methods of use |
| EP3263128A3 (en) * | 2009-04-14 | 2018-01-24 | GlaxoSmithKline Biologicals S.A. | Compositions for immunising against staphylococcus aureus |
| WO2010129674A2 (en) * | 2009-05-05 | 2010-11-11 | New York University | Immunotherapy targeting of the shared abnormal conformational state of amyloidogenic peptides/proteins |
| EP2488198B1 (en) | 2009-10-13 | 2016-09-28 | Rutgers, the State University of New Jersey | Treatment and diagnosis of autoimmune disorders |
| EP4015523A1 (en) * | 2010-05-05 | 2022-06-22 | New York University | Staphylococcus aureus leukocidins, therapeutic compositions, and uses thereof |
| NZ764564A (en) * | 2011-06-19 | 2022-10-28 | Univ New York | Methods of treating and preventing staphylococcus aureus infections and associated conditions |
| US8846609B2 (en) * | 2011-06-19 | 2014-09-30 | New York University | Leukotoxin E/D as a new anti-inflammatory agent and microbicide |
-
2012
- 2012-06-19 NZ NZ764564A patent/NZ764564A/en unknown
- 2012-06-19 MX MX2013014640A patent/MX340446B/es active IP Right Grant
- 2012-06-19 CA CA2839554A patent/CA2839554C/en active Active
- 2012-06-19 ES ES12801920.5T patent/ES2684088T3/es active Active
- 2012-06-19 EP EP20185534.3A patent/EP3777885A1/en not_active Withdrawn
- 2012-06-19 BR BR112013032774A patent/BR112013032774B1/pt active IP Right Grant
- 2012-06-19 CN CN201910111454.9A patent/CN109893644A/zh active Pending
- 2012-06-19 CN CN201280039370.5A patent/CN103717234A/zh active Pending
- 2012-06-19 EP EP12801920.5A patent/EP2720714B1/en active Active
- 2012-06-19 JP JP2014517100A patent/JP6170913B2/ja active Active
- 2012-06-19 ES ES18182774T patent/ES2812181T3/es active Active
- 2012-06-19 EP EP18182774.2A patent/EP3403669B1/en active Active
- 2012-06-19 HU HUE18182774A patent/HUE051832T2/hu unknown
- 2012-06-19 LT LTEP18182774.2T patent/LT3403669T/lt unknown
- 2012-06-19 CN CN201410532443.5A patent/CN104474531A/zh active Pending
- 2012-06-19 BR BR122020000047-3A patent/BR122020000047B1/pt active IP Right Grant
- 2012-06-19 MX MX2016004832A patent/MX357938B/es unknown
- 2012-06-19 WO PCT/US2012/043179 patent/WO2012177658A2/en not_active Ceased
- 2012-06-19 DK DK18182774.2T patent/DK3403669T3/da active
- 2012-06-19 SI SI201231821T patent/SI3403669T1/sl unknown
- 2012-06-19 KR KR1020147001089A patent/KR102050267B1/ko active Active
- 2012-06-19 US US13/527,436 patent/US9091689B2/en active Active
- 2012-06-19 RU RU2014101488A patent/RU2635462C2/ru active
- 2012-06-19 AU AU2012273123A patent/AU2012273123C1/en active Active
-
2013
- 2013-12-11 IL IL229922A patent/IL229922B/en active IP Right Grant
- 2013-12-19 CL CL2013003650A patent/CL2013003650A1/es unknown
-
2015
- 2015-06-11 US US14/736,751 patent/US9481723B2/en active Active
-
2016
- 2016-09-23 US US15/273,914 patent/US9783597B2/en active Active
-
2017
- 2017-07-03 JP JP2017130030A patent/JP6452765B2/ja active Active
- 2017-09-08 US US15/699,345 patent/US10202440B2/en active Active
-
2018
- 2018-04-24 IL IL258886A patent/IL258886A/en unknown
- 2018-12-11 JP JP2018231287A patent/JP6758363B2/ja active Active
-
2019
- 2019-01-07 US US16/241,664 patent/US10669329B2/en active Active
- 2019-07-23 CL CL2019002056A patent/CL2019002056A1/es unknown
-
2020
- 2020-04-28 US US16/860,716 patent/US11078258B2/en active Active
- 2020-08-11 HR HRP20201265TT patent/HRP20201265T1/hr unknown
- 2020-09-01 JP JP2020146494A patent/JP7129451B2/ja active Active
-
2021
- 2021-07-06 US US17/368,566 patent/US20210340228A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014520149A5 (https=) | ||
| RU2014101488A (ru) | Способы лечения и предупреждения инфекций стафилококка золотистого и связанных с ними нарушений | |
| Garcia-Quintanilla et al. | First steps towards a vaccine against Acinetobacter baumannii | |
| JP5763113B2 (ja) | モラクセラ・カタラーリスと上皮細胞、細胞外マトリックス蛋白質及び補体系の相互作用 | |
| Hamaoka et al. | Efficacy comparison of adjuvants in PcrV vaccine against Pseudomonas aeruginosa pneumonia | |
| EP2604692A1 (en) | Immunology treatment for biofilms | |
| KR20220025724A (ko) | 스타필로코커스 단백질 Ａ(ＳｐＡ) 변이체를 포함하는 방법 및 조성물 | |
| US20140271649A1 (en) | Methods and compositions for inhibiting staphylococcus agglutination in blood | |
| JP2008514196A5 (https=) | ||
| Hou et al. | Mechanism of action for an all-in-one monoclonal antibody against Staphylococcus aureus infection | |
| HK40046858A (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
| Xu | Modulating Local Immune Environment to Deter Tuberculosis Progression | |
| NZ730359B2 (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
| NZ710439B2 (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
| HK40000719B (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
| HK40000719A (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
| HK1190640B (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions | |
| NZ619938B2 (en) | Methods of treating and preventing staphylococcus aureus infections and associated conditions |